학술논문

Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial
Document Type
Article
Author
Dimachkie, MazenStatland, JeffreyPasnoor, MamathaJawdat, OmarHeim, AndrewCiersdorff, AliSasidharan, SandhyaCurrence, MelissaLevine, ToddOtutoa, RebeccaCooper, AngelinaMozaffar, TahseenHabib, AliCauchi, JonathanUng, ShannonMathew, VeenaHernandez, IselaGibson, SummerBromberg, MarkMahoney, KyleNeate, CrystalJanecki, TeresaPapadakis, MikeFreimer, MiriamKaschalk, MacKenzieHeintzman, SarahWicklund, MatthewBaines, BrennaVareldzis, AlexaHyslop, EmilyBlume, BriannaCiafaloni, EmmaLuebbe, ElizabethEichinger, KatyMartens, WilliamGregory, StephanieJanciuras, JoanneAmato, AnthonyDoughty, ChristopherRoe, KristenFlynn, PatriciaRusso, EmilyLloyd, ThomasAlbayda, JemimaTiniakou, EleniThomas, SimoneJones, SarahSolorzano, GuillermoElliott, MatthewBurns, TedCrowell, AllisonEggleston, DeborahWagoner, MaryShaibani, AzizOates, ChantaeMachado, PedroHanna, MichaelGreensmith, LindaAhmed, MhoriamVivekanandam, VinojiniAppleby, MatthewRansley, GeorgeEshun, Edwin EshunSkorupinska, IwonaGermain, LouiseLaxa, Ana MariePontes, Joana RocaBellin, AnnaAnifowoshe, DolapoMachado, Pedro MMcDermott, Michael PBlaettler, ThomasSundgreen, ClausAmato, Anthony AGibson, Summer BJones, Sarah MLevine, Todd DLloyd, Thomas EShaibani, Aziz IRosholm, AndersCarstensen, Tim DehliBonefeld, KarenJørgensen, Anders NørkærPhonekeo, KarinaHeim, Andrew JHerbelin, LauraBarohn, Richard JHanna, Michael GDimachkie, Mazen M
Source
In The Lancet Neurology October 2023 22(10):900-911
Subject
Primary Research
Articles
Language
ISSN
1474-4422